Opinion|Videos|August 5, 2024
Approach to Hypertension Management With BTKi Treatment
Medical experts deliberate on strategies for managing newly developed or exacerbated hypertension in patients undergoing treatment with BTK inhibitors for chronic lymphocytic leukemia.
Advertisement
Episodes in this series
- What is your general approach in managing newly acquired or worsening HTN in patients receiving treatment with BTKi inhibitors? What insights do recent data provide?
- Symphony RWD –
Kou, et al. EHA 2024. Abs P1847 - What is the role of antihypertensive medications? Dose reductions/holds?
Advertisement
Related to this article
The top 5 OncLive TV videos of the week cover pancreatic cancer, gastric cancer, GIST, renal cell carcinoma, and chronic lymphocytic leukemia.
Advertisement
Advertisement
Trending on OncLive
1
Five Under 5: Top Oncology Videos for the Week of 8/31/26
2
FDA Approves Camizestrant Plus a CDK4/6 Inhibitor for Emergent ESR1-Mutated HR+, HER2– Advanced Breast Cancer
3
B7-H4–Targeted ADCs Signal a New Frontier for Platinum-Resistant Ovarian and Endometrial Cancer
4
The OncFive: Top Oncology Articles for the Week of 8/30
5